CNTA
Centessa Pharmaceuticals plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%0
Insider buys (3m)
2
Insider sells (3m)
-$16.4M
Net value (3m)
+46.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd · 10 percent owner | Sale | 281,162 | $38 |
| Jun 24, 2026 | INDEX VENTURES LIFE VI (JERSEY) L.P. · 10 percent owner | Sale | 149,421 | $38 |
| May 18, 2026 | Accardi Mario Alberto · director, officer: Chief Executive Officer | F-InKind | 604 | $39 |
| Mar 27, 2026 | Anderson Karen M. · officer: Chief People Officer | Sale | 41,076 | $30 |
| Mar 27, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 41,076 | $8.01 |
| Mar 26, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | M-Exempt | 23,998 | $3.85 |
| Mar 26, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | Sale | 23,998 | $30 |
| Mar 18, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 64,768 | $4.01 |
| Mar 18, 2026 | Anderson Karen M. · officer: Chief People Officer | Sale | 64,768 | $28 |
| Mar 18, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 10,043 | $4.01 |
| Mar 18, 2026 | Anderson Karen M. · officer: Chief People Officer | Sale | 10,043 | $28 |
| Mar 16, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 15,174 | $3.85 |
| Mar 16, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 94,224 | $4.01 |
| Mar 13, 2026 | Anderson Karen M. · officer: Chief People Officer | M-Exempt | 109,398 | $4.01 |
| Mar 13, 2026 | Anderson Karen M. · officer: Chief People Officer | Sale | 12,068 | $27 |
| Mar 13, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | Sale | 61,253 | $26 |
| Mar 13, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | Sale | 11,943 | $27 |
| Mar 13, 2026 | Anderson Karen M. · officer: Chief People Officer | Sale | 107,961 | $26 |
| Feb 3, 2026 | Accardi Mario Alberto · director, officer: Chief Executive Officer | A-Award | 273,000 | $25 |
| Feb 3, 2026 | HUSSAIN IQBAL J · officer: Chief Legal Officer | A-Award | 20,000 | $0.00 |
| Feb 3, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | F-InKind | 14,158 | $25 |
| Feb 3, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | A-Award | 123,000 | $25 |
| Feb 3, 2026 | HUSSAIN IQBAL J · officer: Chief Legal Officer | A-Award | 160,000 | $25 |
| Feb 3, 2026 | Crowley John J · officer: Chief Financial Officer | A-Award | 45,000 | $0.00 |
| Feb 3, 2026 | Weinhoff Gregory M · officer: Chief Business Officer | A-Award | 31,000 | $0.00 |
| Feb 3, 2026 | Kanes Stephen · officer: Chief Medical Officer | A-Award | 120,000 | $0.00 |
| Feb 3, 2026 | Bush Tia L · officer: Chief Technology & Quality Ofc | F-InKind | 8,549 | $25 |
| Feb 3, 2026 | HUSSAIN IQBAL J · officer: Chief Legal Officer | Sale | 38,951 | $25 |
| Feb 3, 2026 | Bush Tia L · officer: Chief Technology & Quality Ofc | A-Award | 140,000 | $25 |
| Feb 3, 2026 | Bush Tia L · officer: Chief Technology & Quality Ofc | A-Award | 35,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 48Increased 52Reduced 47Sold out 161
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | Unchanged | 19,963,157 | Apr 21, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 14,555,555 | Mar 16, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 11,430,455 | May 15, 2026 |
| INDEX VENTURE LIFE ASSOCIATES VI LTD | Unchanged | 9,961,789 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 8,925,010 | May 15, 2026 |
| PENTWATER CAPITAL MANAGEMENT LP | New Position | 8,170,000 | May 15, 2026 |
| FMR LLC | Reduced | 6,852,047 | May 15, 2026 |
| ECOR1 CAPITAL, LLC | Increased | 6,410,800 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 5,258,903 | May 29, 2026 |
| CAPITAL WORLD INVESTORS | Increased | 4,832,548 | May 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 4,809,000 | May 15, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 4,286,480 | May 15, 2026 |
| MORGAN STANLEY | Increased | 4,268,353 | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | New Position | 3,574,048 | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 3,492,977 | May 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 24, 2026